Ali Maleki, Arash Arashkia, Mohammad Hassan Pouriayevali, Tahmineh Jalali, Mahsa Tavakoli, Mohammad Modoodi Yaghooti, Zahra Ahmadi, Farideh Niknam Oskouei, Zahra Fereydouni, Kayhan Azadmanesh, Mostafa Salehi-Vaziri, Mahdi Rohani
{"title":"伊朗在 2022 年疫情爆发期间首次出现 Mpox 感染病例。","authors":"Ali Maleki, Arash Arashkia, Mohammad Hassan Pouriayevali, Tahmineh Jalali, Mahsa Tavakoli, Mohammad Modoodi Yaghooti, Zahra Ahmadi, Farideh Niknam Oskouei, Zahra Fereydouni, Kayhan Azadmanesh, Mostafa Salehi-Vaziri, Mahdi Rohani","doi":"10.3855/jidc.18589","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The unexpected outbreak of human Mpox infection beginning in some European countries that were non-endemic for Mpox stunned the world during the Coronavirus Disease 2019 (COVID-19) pandemic in May 2022. The re-emerging Mpox outbreak, which has a greater capacity for human-to-human transmission, was mainly due to traveling. In this paper, we describe the first case of the disease was observed in an Iranian woman infected by her husband who had a history of traveling to Canada.</p><p><strong>Case report: </strong>The 34-year-old woman had flu-like syndrome with some skin rashes on her hand, finger, and arm. No antivirals were prescribed in this case, and supportive care was used to help her recover. RT-PCR and Sanger sequencing were used to analyze the sample from the oropharyngeal swab and the rash, and the results confirmed the Mpox infection.</p><p><strong>Conclusions: </strong>The risk of infectious disease outbreaks after COVID-19, such as Mpox, is of great importance, and health systems should be vigilant for timely identification and preparedness.</p>","PeriodicalId":49160,"journal":{"name":"Journal of Infection in Developing Countries","volume":"18 9","pages":"1450-1452"},"PeriodicalIF":1.4000,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The first case of Mpox infection in Iran during the 2022 outbreak.\",\"authors\":\"Ali Maleki, Arash Arashkia, Mohammad Hassan Pouriayevali, Tahmineh Jalali, Mahsa Tavakoli, Mohammad Modoodi Yaghooti, Zahra Ahmadi, Farideh Niknam Oskouei, Zahra Fereydouni, Kayhan Azadmanesh, Mostafa Salehi-Vaziri, Mahdi Rohani\",\"doi\":\"10.3855/jidc.18589\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>The unexpected outbreak of human Mpox infection beginning in some European countries that were non-endemic for Mpox stunned the world during the Coronavirus Disease 2019 (COVID-19) pandemic in May 2022. The re-emerging Mpox outbreak, which has a greater capacity for human-to-human transmission, was mainly due to traveling. In this paper, we describe the first case of the disease was observed in an Iranian woman infected by her husband who had a history of traveling to Canada.</p><p><strong>Case report: </strong>The 34-year-old woman had flu-like syndrome with some skin rashes on her hand, finger, and arm. No antivirals were prescribed in this case, and supportive care was used to help her recover. RT-PCR and Sanger sequencing were used to analyze the sample from the oropharyngeal swab and the rash, and the results confirmed the Mpox infection.</p><p><strong>Conclusions: </strong>The risk of infectious disease outbreaks after COVID-19, such as Mpox, is of great importance, and health systems should be vigilant for timely identification and preparedness.</p>\",\"PeriodicalId\":49160,\"journal\":{\"name\":\"Journal of Infection in Developing Countries\",\"volume\":\"18 9\",\"pages\":\"1450-1452\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2024-09-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Infection in Developing Countries\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3855/jidc.18589\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection in Developing Countries","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3855/jidc.18589","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
The first case of Mpox infection in Iran during the 2022 outbreak.
Introduction: The unexpected outbreak of human Mpox infection beginning in some European countries that were non-endemic for Mpox stunned the world during the Coronavirus Disease 2019 (COVID-19) pandemic in May 2022. The re-emerging Mpox outbreak, which has a greater capacity for human-to-human transmission, was mainly due to traveling. In this paper, we describe the first case of the disease was observed in an Iranian woman infected by her husband who had a history of traveling to Canada.
Case report: The 34-year-old woman had flu-like syndrome with some skin rashes on her hand, finger, and arm. No antivirals were prescribed in this case, and supportive care was used to help her recover. RT-PCR and Sanger sequencing were used to analyze the sample from the oropharyngeal swab and the rash, and the results confirmed the Mpox infection.
Conclusions: The risk of infectious disease outbreaks after COVID-19, such as Mpox, is of great importance, and health systems should be vigilant for timely identification and preparedness.
期刊介绍:
The Journal of Infection in Developing Countries (JIDC) is an international journal, intended for the publication of scientific articles from Developing Countries by scientists from Developing Countries.
JIDC is an independent, on-line publication with an international editorial board. JIDC is open access with no cost to view or download articles and reasonable cost for publication of research artcles, making JIDC easily availiable to scientists from resource restricted regions.